S-4 Filing

Breeze shareholders last year approved a deadline extension up to June 26 this year, although further redemptions left the SPAC with $12.6 million in trust, according to a regulatory filing at that time. That has caused some challenges for the SPAC in maintaining Nasdaq listing requirements. Breeze warned in the proxy that it may not be able to continue listing on the exchange -- which is a requirement to close the deal with TV Ammo.

Formed by Atlas Merchant Capital, the SPAC raised $280 million in a 2021 IPO with plans to acquire a business in the financial services and financial technology sectors.

The target is a U.S. company with offices and locations worldwide “that has developed and patented state-of-the-art technology that allows crystalline lagoons of unlimited sizes to be built and maintained at low costs, offering an idyllic beach lifestyle anywhere in the world,” according to its website.

The target is a satellite technology company providing multi-orbit broadband connectivity solutions.

If approved, stockholders in the cloud computing target would own approximately 70.6% of the outstanding shares.

Founded in 2012, MindMaze is engaged in brain technology with a mission to accelerate humanity’s ability to recover, learn and adapt.

Terms call for the issuance of 9 million shares to New Era Helium, plus 1 million earnout shares in two equal tranches if certain financial meilestones are reached.

If the extension is approved, the new deadline will mark the three-year anniversary of the SPAC's $90 million IPO. Inception Growth is now down to about $33 million in trust as of May 10, according to the proxy.

TOYO focuses on solar photovoltaic products in Southeast Asia. The company plans to invest $350 million in a cell factory in Phu Tho Province, Vietnam.

Based in Emeryville, CA, Profusa “is pioneering the next generation of personalized medicine via the development of novel tissue-integrated biosensors. Profusa’s technology addresses the human body’s response to the presence of foreign material, enabling long-term monitoring of various biochemical parameters in real-time.”